CD55 antibody (AA 238-357)
Quick Overview for CD55 antibody (AA 238-357) (ABIN7539640)
Target
See all CD55 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 238-357
-
Purpose
- CD55 Antibody
-
Purification
- Purified antibody
-
Immunogen
- Purified recombinant fragment of human CD55 (AA: 238-357) expressed in E. Coli.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
ELISA: 1/10000
FCM: 1/200 - 1/400
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Alternative Name
- CD55
-
Background
-
This gene encodes a protein involved in the regulation of the complement cascade. The encoded glycoprotein is also known as the decay-accelerating factor (DAF), binding of DAF to complement proteins accelerates their decay, disrupting the cascade and preventing damage to host cells. Antigens present on the DAF glycoprotein constitute the Cromer blood group system (CROM). Two alternatively spliced transcripts encoding different proteins have been identified. The predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma component proteins but an alternatively spliced transcript produces a soluble protein present at much lower levels. Additional, alternatively spliced transcript variants have been described, but their biological validity has not been determined.
-
Molecular Weight
- 41.4 kDa
-
UniProt
- P08174
-
Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity
Target
-